Molecular Characterization of Microrna Interference and Aristolochic Acid Intoxication Found in Upper Tract Urothelial Carcinoma in Patients with Balkan Endemic Nephropathy: A Systematic Review of the Current Literature
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Polenakovic M, Stefanovic V. Balkan nephropathy. In: Cameron J. S., Davison A. M., Grunfeld J. P., Kerr D., Ritz E., editors. Oxford Textbook of Clinical Nephrology. 1st. Oxford, UK: Oxford University Press; 1992. pp. 857–866.PolenakovicMStefanovicV.Balkan nephropathy. In:CameronJ. S.DavisonA. M.GrunfeldJ. P.KerrD.RitzE.editors.1st.Oxford, UK:Oxford University Press;1992. pp.857–866.Search in Google Scholar
Djukanović L, Radovanović Z. Balkan endemic nephropathy. In: De Broe M. E., Porter G. A., Bennett W. M., Verpooten G. A., editors. Clinical Nephrotoxins. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2003. pp. 587–601.DjukanovićLRadovanovićZ.Balkan endemic nephropathy. In:De BroeM. E.PorterG. A.BennettW. M.VerpootenG. A.editors.Dordrecht, The Netherlands:Kluwer Academic Publishers;2003. pp.587–601.Search in Google Scholar
Stefanovic V, Radovanovic Z. Balkan endemic nephropathy and associated urothelial cancer. Nature Clinical Practice Urology. 2008;5(2):105–112.StefanovicVRadovanovicZ.Balkan endemic nephropathy and associated urothelial cancer.2008;5(2):105–112.Search in Google Scholar
Stefanovic V. Current status and research beyond year 2010 in Balkan endemic nephropathy. BANTAO Journal. 2009;7(2):4–9.StefanovicV.Current status and research beyond year 2010 in Balkan endemic nephropathy.2009;7(2):4–9.Search in Google Scholar
Stefanovic V, Polenakovic M, Toncheva D. Urothelial carcinoma associated with Balkan endemic nephropathy. A worldwide disease. Pathologie Biologie. 2011;59(5):286–291.StefanovicVPolenakovicMTonchevaD.Urothelial carcinoma associated with Balkan endemic nephropathy. A worldwide disease.2011;59(5):286–291.Search in Google Scholar
Polenakovic M, Stefanović V. What do we know about the Balkan endemic nephropathy and the uroepithelial tumors? Prilozi. 2014;35(1):11–15.PolenakovicMStefanovićV.What do we know about the Balkan endemic nephropathy and the uroepithelial tumors?2014;35(1):11–15.Search in Google Scholar
Velickovic L. J, Hattori T, Stefanovic V. Molecular markers in upper urothelial carcinoma associated to Balkan endemic nephropathy. Aristolochic acid as the major risk factor of the worldwide disease. The-ScientificWorldJournal. 2009;9: 1360–1373.VelickovicL. JHattoriTStefanovicV.Molecular markers in upper urothelial carcinoma associated to Balkan endemic nephropathy. Aristolochic acid as the major risk factor of the worldwide disease.2009;9:1360–1373.Search in Google Scholar
Toncheva D, Dimitrov T, Stojanova S. Etiology of Balkan endemic nephropathy: a multifactorial disease? European Journal of Epidemiology. 1998;14(4):389–394.TonchevaDDimitrovTStojanovaS.Etiology of Balkan endemic nephropathy: a multifactorial disease?1998;14(4):389–394.Search in Google Scholar
Ivic M. The problem of etiology of endemic nephropathy. Lijecnicki Vjesnik. 1969;91: 1278–1281.IvicM.The problem of etiology of endemic nephropathy.1969;91:1278–1281.Search in Google Scholar
De Broe M. E. Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy. Kidney International. 2012;81(6):513–515.De BroeM. E.Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy.2012;81(6):513–515.Search in Google Scholar
Vanherweghem J.-. Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. The Lancet. 1993;341(8842):387–391.VanherweghemJ.-.DepierreuxMTielemansCRapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs.1993;341(8842):387–391.Search in Google Scholar
Nortier J. L, Martinez M.-C. M, Schmeiser H. H, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fang chi) The New England Journal of Medicine. 2000;342(23):1686–1692.NortierJ. LMartinezM.-C. MSchmeiserH. HUrothelial carcinoma associated with the use of a Chinese herb (Aristolochia fang chi)2000;342(23):1686–1692.Search in Google Scholar
Vanhaelen M, Vanhaelen-Fastre R, But P, Vanherweghem J.-L. Identification of aristolochic acid in Chinese herbs. The Lancet. 1994;343(8890):p. 174.VanhaelenMVanhaelen-FastreRButPVanherweghemJ.-L.Identification of aristolochic acid in Chinese herbs.1994;343(8890):p.174.Search in Google Scholar
Yang C.-S, Lin C.-H, Chang S.-H, Hsu H.-C. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. American Journal of Kidney Diseases. 2000;35(2):313–318.YangC.-SLinC.-HChangS.-HHsuH.-C.Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs.2000;35(2):313–318.Search in Google Scholar
Chang C.-H, Wang Y.-M, Yang A.-H, Chiang S.-S. Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications. American Journal of Nephrology. 2001;21(6):441–448.ChangC.-HWangY.-MYangA.-HChiangS.-S.Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications.2001;21(6):441–448.Search in Google Scholar
Lord G. M, Cook T, Arlt V. M, Schmeiser H. H, Williams G, Pusey C. D. Urothelial malignant disease and Chinese herbal nephropathy. The Lancet. 2001;358(9292):1515–1516.LordG. MCookTArltV. MSchmeiserH. HWilliamsGPuseyC. D.Urothelial malignant disease and Chinese herbal nephropathy.2001;358(9292):1515–1516.Search in Google Scholar
Li X.-B, Xing N.-Z, Wang Y, Hu X.-P, Yin H, Zhang X.-D. Transitional cell carcinoma in renal transplant recipients: a single center experience. International Journal of Urology. 2008;15(1):53–57.LiX.-BXingN.-ZWangYHuX.-PYinHZhangX.-D.Transitional cell carcinoma in renal transplant recipients: a single center experience.2008;15(1):53–57.Search in Google Scholar
Cosyns J, Jadoul M, Squifflet J.-P, Van Cangh P, van Ypersele de Strihou C. Urothelial malignancy innephropathy due to Chinese herbs. Lancet 1994, 344, 188.CosynsJJadoulMSquiffletJ.-PVan CanghPvan Ypersele de StrihouC.Urothelial malignancy innephropathy due to Chinese herbs.1994,344,188.Search in Google Scholar
Nortier J.L, Martinez Muniz M.-C, Schmeiser H.H, Arlt V.M, Bieler C.A, Petein, M, Depierreux, M.F, de Pauw L, Abramowicz D, Vereerstraeten P, et al. Urothelial carcinoma associated with the use of a Chinese herb. N. Engl. J. Med. 2000, 342, 1686–1692.NortierJ.LMartinez MunizM.-CSchmeiserH.HArltV.MBielerC.APeteinMDepierreuxM.Fde PauwLAbramowiczDVereerstraetenPUrothelial carcinoma associated with the use of a Chinese herb.2000,342,1686–1692.Search in Google Scholar
World Health Organization. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans; IARC Press: Lyon, France, 2002; Volume 82.World Health Organization.Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. In;IARC Press:Lyon, France,2002; Volume82.Search in Google Scholar
Debelle F.D, Vanherweghem J.-L, and Nortier J.L. Aristolochic acid nephropathy: A worldwide problem. Kidney Int. 2008, 74, 158–169.DebelleF.DVanherweghemJ.-LNortierJ.L.Aristolochic acid nephropathy: A worldwide problem.2008,74,158–169.Search in Google Scholar
Chen C.-H, Dickman K.G, Moriya M, Zavadil J, Sidorenko V.S, Edwards K.L, Gnatenko D.V, Wu L, Turesky R.J, Wu X.-R, et al. Aristolochic acidassociated urothelial cancer in Taiwan. Proc. Natl. Acad. Sci. USA 2012, 109, 8241–8246.ChenC.-HDickmanK.GMoriyaMZavadilJSidorenkoV.SEdwardsK.LGnatenkoD.VWuLTureskyR.JWuX.-RAristolochic acidassociated urothelial cancer in Taiwan.2012,109,8241–8246.Search in Google Scholar
Schmeiser H.H, Janssen J.W.G, Lyons J, Scherf H.R, Pfau W, Buchmann A, Bartram C.R, Wiessler M. Aristolochic Acid Activates ras Genes in Rat Tumors at Deoxyadenosine Residues. Cancer Res. 1990, 50, 5464–5469.SchmeiserH.HJanssenJ.W.GLyonsJScherfH.RPfauWBuchmannABartramC.RWiesslerM.Aristolochic Acid Activates ras Genes in Rat Tumors at Deoxyadenosine Residues.1990,50,5464–5469.Search in Google Scholar
Lord G.M, Hollstein M, Arlt V.M, Roufosse C, Pusey C.D, Cook T, Schmeiser H.H. DNA adducts and p53 mutations in a patient with aristolochic acidassociated nephropathy. Am. J. Kidney Dis. 2004, 43,e18.1–e18.7.LordG.MHollsteinMArltV.MRoufosseCPuseyC.DCookTSchmeiserH.H.DNA adducts and p53 mutations in a patient with aristolochic acidassociated nephropathy.2004,43,e18.1–e18.7.Search in Google Scholar
Hollstein M, Moriya M, Grollman A.P, Olivier M. Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental caecinogen Hollstein M, Moriya M, Grollman A.P, OlivierHollsteinMMoriyaMGrollmanA.POlivierM.Search in Google Scholar
Arlt V.M, Stiborova M, Schmeiser H.H. Aristolochic acid as a probable human cancer hazard in herbal remedies: A review. Mutagenesis 2002, 17, 265–277ArltV.MStiborovaMSchmeiserH.H.Aristolochic acid as a probable human cancer hazard in herbal remedies: A review.2002,17,265–277Search in Google Scholar
Slade N, Moll U.M, Brdar B, Zori´c A, Jelakovi´c B. p53 mutations as fingerprints for aristolochic acid— An environmental carcinogen in endemic (Balkan) nephropathy. Mutat. Res. Fundam. Mol. Mech. Mutagen. 2009,663, 1–6.SladeNMollU.MBrdarBZori´cAJelakovi´cB.p53 mutations as fingerprints for aristolochic acid— An environmental carcinogen in endemic (Balkan) nephropathy.2009,663,1–6.Search in Google Scholar
Hoang M.L, Chen C.-H, Sidorenko V.S, He J, Dickman K.G, Yun B.H, Moriya M, Niknafs N, Douville C, Karchin R, et al. Mutational Signature of Aristolochic Acid Exposure as Revealed by Whole Exome sequencing.Sci.Trans.Med.2013,5.HoangM.LChenC.-HSidorenkoV.SHeJDickmanK.GYunB.HMoriyaMNiknafsNDouvilleCKarchinRMutational Signature of Aristolochic Acid Exposure as Revealed by Whole Exome sequencing.2013,5.Search in Google Scholar
Moriya M, Slade N, Brdar B, Medverec Z, Tomic K, Jelakovi´c B, Wu L,Truong S, Fernandes A, Grollman A.P. TP53 Mutational signature for aristolochic acid: An environmental carcinogen. Int. J. Cancer 2011, 129, 1532–1536.MoriyaMSladeNBrdarBMedverecZTomicKJelakovi´cBWuLTruongSFernandesAGrollmanA.P.TP53 Mutational signature for aristolochic acid: An environmental carcinogen.2011,129,1532–1536.Search in Google Scholar
Aydin S, Dekairelle A.-F, Ambroise J, Durant J.-F, Heusterspreute M, Cosyns Y.G.J.-P, Gala J.-L. Unambiguous Detection of Multiple TP53 Gene Mutations in AAN-Associated Urothelial Cancer in Belgium Using Laser Capture Microdissection. PLoS ONE 2014, 9, e106301.AydinSDekairelleA.-FAmbroiseJDurantJ.-FHeusterspreuteMCosynsY.G.J.-PGalaJ.-L.Unambiguous Detection of Multiple TP53 Gene Mutations in AAN-Associated Urothelial Cancer in Belgium Using Laser Capture Microdissection.2014,9,e106301.Search in Google Scholar
Wang Y, Meng F, Arlt VM, Mei N, Chen T, Parsons BL. Aristolochic acid-induced carcinogenesis examined by ACB-PCR quantification of H-Ras and KRas mutant fraction. Mutagenesis. 2011;26: 619–628.WangYMengFArltVMMeiNChenTParsonsBL.Aristolochic acid-induced carcinogenesis examined by ACB-PCR quantification of H-Ras and KRas mutant fraction.2011;26:619–628.Search in Google Scholar
Olivier M, Hollstein M, Schmeiser HH, Straif K, Wild CP. Upper urinary tract urothelial cancer: where it is A: T. Nat Rev. 2012;12: 503–504.OlivierMHollsteinMSchmeiserHHStraifKWildCP.Upper urinary tract urothelial cancer: where it is A: T.2012;12:503–504.Search in Google Scholar
Poon SL, Pang ST, McPherson JR, et al. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool. Sci Transl Med 2013;5: 197ra101.PoonSLPangSTMcPhersonJRGenome-wide mutational signatures of aristolochic acid and its application as a screening tool.2013;5:197ra101.Search in Google Scholar
Simmons D. Epigenetic influence and disease. Nature Education. 2008;1(1, article 6)SimmonsD.Epigenetic influence and disease..2008;1(1, article 6)Search in Google Scholar
Staneva R, Rukova B, Hadjidekova S, et al. Whole genome methylation array analysis reveals new aspects in Balkan endemic nephropathy etiology. BMC Nephrology. 2013;14, article 225StanevaRRukovaBHadjidekovaSWhole genome methylation array analysis reveals new aspects in Balkan endemic nephropathy etiology..2013;14, article 225Search in Google Scholar
Kocic G, Cukuranovic J, Stoimenov T. J., et al. Global and specific histone acetylation pattern in patients with Balkan endemic nephropathy, a worldwide disease. Renal Failure. 2014;36(7):1078–1082.KocicGCukuranovicJStoimenovT. J.Global and specific histone acetylation pattern in patients with Balkan endemic nephropathy, a worldwide disease.2014;36(7):1078–1082.Search in Google Scholar
Neely L. A., Rieger-Christ K. M., Neto B. S., et al. A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urologic Oncology: Seminars and Original Investigations. 2010;2 8(1):39–48.NeelyL. A.Rieger-ChristK. M.NetoB. S.A microRNA expression ratio defining the invasive phenotype in bladder tumors.2010;28(1):39–48.Search in Google Scholar
Wang G, Zhang H, He H, et al. Up-regulation of microRNA in bladder tumor tissue is not common. International Urology and Nephrology. 2010;42(1):95–102.WangGZhangHHeHUp-regulation of microRNA in bladder tumor tissue is not common.2010;42(1):95–102.Search in Google Scholar
Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294(5543):853–858.Lagos-QuintanaMRauhutRLendeckelWTuschlT.Identification of novel genes coding for small expressed RNAs.2001;294(5543):853–858.Search in Google Scholar
Bartel D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.BartelD. P.MicroRNAs: genomics, biogenesis, mechanism, and function.2004;116(2):281–297.Search in Google Scholar
Alvarez-Garcia I, Miska E. A. MicroRNA functions in animal development and human disease. Development. 2005;132(21):4653–4662.Alvarez-GarciaIMiskaE. A.MicroRNA functions in animal development and human disease.2005;132(21):4653–4662.Search in Google Scholar
Calin G. A, Sevignani C, Dumitru C. D, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(9):2999–3004.CalinG. ASevignaniCDumitruC. DHuman microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.2004;101(9):2999–3004.Search in Google Scholar
Nikolova D, Toncheva D. RNA interferenceregulations and application in oncology. Journal of Cancer Molecules. 2008;4(3):67–77.NikolovaDTonchevaD.RNA interferenceregulations and application in oncology.2008;4(3):67–77.Search in Google Scholar
Kent O. A, Mendell J. T. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene. 2006;25(46):6188–6196.KentO. AMendellJ. T.A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.2006;25(46):6188–6196.Search in Google Scholar
Gottardo F, Liu C. G, Ferracin M, et al. MicroRNA profiling in kidney and bladder cancers. Urologic Oncology: Seminars and Original Investigations. 2007;25(5):387–392.GottardoFLiuC. GFerracinMMicroRNA profiling in kidney and bladder cancers.2007;25(5):387–392.Search in Google Scholar
Lu J, Getz G, Miska E. A, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834–838.LuJGetzGMiskaE. AMicroRNA expression profiles classify human cancers.2005;435(7043):834–838.Search in Google Scholar
Stenvang J, Silahtaroglu A. N, Lindow M, Elmen J, Kauppinen S. The utility of LNA in microRNAbased cancer diagnostics and therapeutics. Seminars in Cancer Biology. 2008;18(2):89–102.StenvangJSilahtarogluA. NLindowMElmenJKauppinenS.The utility of LNA in microRNAbased cancer diagnostics and therapeutics.2008;18(2):89–102.Search in Google Scholar
Tao L, Zeng Y, Wang J, et al. Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo. Molecular Medicine Reports. 2015;12(5):6533–6546.TaoLZengYWangJDifferential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo.2015;12(5):6533–6546.Search in Google Scholar
Meng F, Li Z, Yan J, et al. Tissue-specific microRNA responses in rats treated with mutagenic and carcinogenic doses of aristolochic acid. Mutagenesis. 2014;29(5):357–365.MengFLiZYanJTissue-specific microRNA responses in rats treated with mutagenic and carcinogenic doses of aristolochic acid.2014;29(5):357–365.Search in Google Scholar
Wang Y.-Y, Li Z, Chen T, Zhao X.-M. Understanding the aristolochic acid toxicities in rat kidneys with regulatory networks. IET Systems Biology. 2015;9(4):141–146.WangY.-YLiZChenTZhaoX.-M.Understanding the aristolochic acid toxicities in rat kidneys with regulatory networks.2015;9(4):141–146.Search in Google Scholar
Popovska-Jankovic K, Noveski P, JankovicVelickovic Lj, Stojnev S, Cukuranovic R, Stefanovic V, Toncheva D, Staneva R, Polenakovic M, PlaseskaKaranfilska D. MicroRNA Profiling in Patients with Upper Tract Urothelial Carcinoma Associated with Balkan Endemic Nephropathy. Biomed Res Int. 2016: 7450461.Popovska-JankovicKNoveskiPJankovicVelickovicLjStojnevSCukuranovicRStefanovicVTonchevaDStanevaRPolenakovicMPlaseskaKaranfilskaD.MicroRNA Profiling in Patients with Upper Tract Urothelial Carcinoma Associated with Balkan Endemic Nephropathy.2016:7450461.Search in Google Scholar
Wei S, Yao Y, Gupta P. K, Bing Z. miRNA expression in lower and upper urothelial carcinoma and the potential clinical application. Proceedings of the 102nd United States and Canadian Academy of Pathology Annual Meeting (USCAP ‘13); March 2013; Baltimore, Md, USA. Baltimore Convention Center.WeiSYaoYGuptaP. KBingZ.miRNA expression in lower and upper urothelial carcinoma and the potential clinical application.;March2013;Baltimore, Md, USA.Baltimore Convention Center.Search in Google Scholar
Blick C, Ramachandran A, Wigfield S, McCormick R, Jubb A, Buffa FM, et al. Hypoxia regulates FGFR3 expression via HIF-1alpha and miR100 and contributes to cell survival in non-muscle invasive bladder cancer. Br J Cancer. 2013; 109 (1):509.BlickCRamachandranAWigfieldSMcCormickRJubbABuffaFMHypoxia regulates FGFR3 expression via HIF-1alpha and miR100 and contributes to cell survival in non-muscle invasive bladder cancer.2013;109(1):509.Search in Google Scholar
Ratert N, Meyer HA, Jung M, Mollenkopf HJ, Wagner I, Miller K, Kilic E, Erbersdobler A, Weikert S, Jung K. Reference miRNAs for miRNAome analysis of urothelial carcinomas. PLoS One. 2012; 7:e39309.RatertNMeyerHAJungMMollenkopfHJWagnerIMillerKKilicEErbersdoblerAWeikertSJungK.Reference miRNAs for miRNAome analysis of urothelial carcinomas.2012;7:e39309.Search in Google Scholar
Wu C.F, Pang S.T, Shee J.J, Chang P.L, Chuang C.K, Chen C.S, Liao S.K, Weng W.H. Identification of genetic alterations in upper urinary tract urothelial carcinoma in end-stage renal disease patients. Genes Chromosomes Cancer 2010, 49, 928–934.WuC.FPangS.TSheeJ.JChangP.LChuangC.KChenC.SLiaoS.KWengW.H.Identification of genetic alterations in upper urinary tract urothelial carcinoma in end-stage renal disease patients.2010,49,928–934.Search in Google Scholar
Kurataka O and Takahiro O. Genetic Networks Lead and Follow Tumor Development: MicroRNA Regulation of Cell Cycle and Apoptosis in the p53 Pathways. Biomed Res Int. 2014; 2014: 749724.KuratakaOTakahiroO.Genetic Networks Lead and Follow Tumor Development: MicroRNA Regulation of Cell Cycle and Apoptosis in the p53 Pathways.2014;2014:749724.Search in Google Scholar
Munekazu Yamakuchi. MicroRNA Regulation of SIRT1. Front Physiol. 2012; 3: 68.YamakuchiMunekazu.MicroRNA Regulation of SIRT1.2012;3:68.Search in Google Scholar
Pramanik D, Campbell N. R, Karikari C, Chivukula R, Kent O. A, Mendell J. T, Maitra A. Restitution of tumor suppressor microRNAs using a systemic nano vector inhibits pancreatic cancer growth in mice. Mol. Cancer Ther. 2011; 10, 1470–1480.PramanikDCampbellN. RKarikariCChivukulaRKentO. AMendellJ. TMaitraA.Restitution of tumor suppressor microRNAs using a systemic nano vector inhibits pancreatic cancer growth in mice.2011;10,1470–1480.Search in Google Scholar
Pogribny I P, Muskhelishvili L, Tryndyak V. P, Beland F. A. The tumor-promoting activity of 2acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation. Toxicol. Appl. Pharmacol. 2009; 235, 305–311.PogribnyI PMuskhelishviliLTryndyakV. PBelandF. A.The tumor-promoting activity of 2acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation.2009;235,305–311.Search in Google Scholar
Yunshu Y,Yang L, Yunwei W, Yongyi Ch, Jinxin Zh, Yanhui J, Jun T, Dahai H. Regulation of SIRT1 and Its Roles in Inflammation. Front Immunol. 2022; 13: 831168.YunshuYYangLYunweiWYongyiChJinxinZhYanhuiJJunTDahaiH.Regulation of SIRT1 and Its Roles in Inflammation.2022;13:831168.Search in Google Scholar
Ivic N. The problem of etiology of endemic nephropathy. Lijecnicki Vjesnik. 1969; 91: 1278–1281.IvicN.The problem of etiology of endemic nephropathy.1969;91:1278–1281.Search in Google Scholar
Pavlović Nikola. Balkan endemic nephropathy—current status and future perspectives. Clinical Kidney Journal. 2013; 257–26.NikolaPavlović.Balkan endemic nephropathy—current status and future perspectives..2013;257–26.Search in Google Scholar
Jadot I,Declèves A, Nortier J, Caron N. An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature. Int. J. Mol. Sci. 2017; 18(2), 297.JadotIDeclèvesANortierJCaronN.An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature.2017;18(2),297.Search in Google Scholar